Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

BioAtla (BCAB) Assets Average (2021 - 2025)

BioAtla's Assets Average history spans 5 years, with the latest figure at $14.9 million for Q4 2025.

  • For Q4 2025, Assets Average fell 74.07% year-over-year to $14.9 million; the TTM value through Dec 2025 reached $14.9 million, down 74.07%, while the annual FY2025 figure was $33.1 million, 61.5% down from the prior year.
  • Assets Average reached $14.9 million in Q4 2025 per BCAB's latest filing, down from $21.5 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $266.0 million in Q4 2021 to a low of $14.9 million in Q4 2025.
  • Average Assets Average over 5 years is $148.8 million, with a median of $178.8 million recorded in 2023.
  • Peak YoY movement for Assets Average: grew 2.33% in 2022, then plummeted 74.07% in 2025.
  • A 5-year view of Assets Average shows it stood at $266.0 million in 2021, then decreased by 22.02% to $207.4 million in 2022, then tumbled by 34.67% to $135.5 million in 2023, then plummeted by 57.69% to $57.3 million in 2024, then tumbled by 74.07% to $14.9 million in 2025.
  • Per Business Quant, the three most recent readings for BCAB's Assets Average are $14.9 million (Q4 2025), $21.5 million (Q3 2025), and $32.7 million (Q2 2025).